These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26023151)

  • 1. How Can We Identify the Elimination of Infectious Diseases? Experience From an Active Measles Laboratory Surveillance System in the Republic of Korea.
    Yang TU; Kang HJ; Eom HE; Park YJ; Park O; Kim SJ; Nam JG; Kim SS; Jeong EK
    Asia Pac J Public Health; 2015 Nov; 27(8 Suppl):101S-109S. PubMed ID: 26023151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea.
    Choe YJ; Jee Y; Oh MD; Lee JK
    J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S115-21. PubMed ID: 26617443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress Toward Measles Elimination - Bangladesh, 2000-2016.
    Khanal S; Bohara R; Chacko S; Sharifuzzaman M; Shamsuzzaman M; Goodson JL; Dabbagh A; Kretsinger K; Dhongde D; Liyanage J; Bahl S; Thapa A
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(28):753-757. PubMed ID: 28727678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress Toward Measles Elimination - Nepal, 2007-2014.
    Khanal S; Sedai TR; Choudary GR; Giri JN; Bohara R; Pant R; Gautam M; Sharapov UM; Goodson JL; Alexander J; Dabbagh A; Strebel P; Perry RT; Bah S; Abeysinghe N; Thapa A
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(8):206-10. PubMed ID: 26937619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular surveillance shows progress in measles elimination process].
    Santibanez S; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1238-42. PubMed ID: 23990085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards measles elimination, Philippines, 1998–2014.
    Wkly Epidemiol Rec; 2015 Apr; 90(15):149-59. PubMed ID: 25864232
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful control and impending elimination of measles in the Islamic Republic of Iran.
    Zahraei SM; Gouya MM; Azad TM; Soltanshahi R; Sabouri A; Naouri B; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S305-11. PubMed ID: 21666178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission.
    Choi WS; Sniadack DH; Jee Y; Go UY; So JS; Cho H; Bae GR; Lee DH; Kim K; Yoon HS; Chung YS; Kang C; Park H; Park O; Lee JK
    J Infect Dis; 2011 Jul; 204 Suppl 1():S483-90. PubMed ID: 21666204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards measles elimination -South-East Asia Region, 2003-2013.
    Wkly Epidemiol Rec; 2015 Jun; 90(24):297-305. PubMed ID: 26072524
    [No Abstract]   [Full Text] [Related]  

  • 12. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward the 2012 measles elimination goal--Western Pacific Region, 1990-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):669-73. PubMed ID: 19553903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.
    Coughlin MM; Beck AS; Bankamp B; Rota PA
    Viruses; 2017 Jan; 9(1):. PubMed ID: 28106841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms.
    Mulders MN; Serhan F; Goodson JL; Icenogle J; Johnson BW; Rota PA
    J Infect Dis; 2017 Jul; 216(suppl_1):S324-S330. PubMed ID: 28838191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards measles elimination – African Region, 2013–2016.
    Wkly Epidemiol Rec; 2017 May; 92(18):229-39. PubMed ID: 28530366
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles - The epidemiology of elimination.
    Durrheim DN; Crowcroft NS; Strebel PM
    Vaccine; 2014 Dec; 32(51):6880-6883. PubMed ID: 25444814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.
    Dabbagh A; Patel MK; Dumolard L; Gacic-Dobo M; Mulders MN; Okwo-Bele JM; Kretsinger K; Papania MJ; Rota PA; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2017 Oct; 66(42):1148-1153. PubMed ID: 29073125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Global Measles Laboratory Network.
    Featherstone D; Brown D; Sanders R
    J Infect Dis; 2003 May; 187 Suppl 1():S264-9. PubMed ID: 12721924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of COVID-19 on the laboratory turn-around time of vaccine-preventable disease surveillance: the case of measles in South Sudan.
    Kunjok DM; Zingbondo IM
    Pan Afr Med J; 2020; 37():245. PubMed ID: 33552363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.